We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+353.09%
AUM
$1.06B
AUM Growth
+$51M
Cap. Flow
-$6.45M
Cap. Flow %
-0.61%
Top 10 Hldgs %
22.77%
Holding
281
New
13
Increased
86
Reduced
117
Closed
8

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$10.6M
2
VZ icon
Verizon
VZ
+$9.19M
3
AMGN icon
Amgen
AMGN
+$8.49M
4
AZO icon
AutoZone
AZO
+$2.55M
5
AYI icon
Acuity Brands
AYI
+$1.74M

Sector Composition

Rank Sector Weight
1 Healthcare 15.64%
2 Technology 13.22%
3 Industrials 11.56%
4 Consumer Staples 10.48%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
26
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$12.8M 1.2%
54,231
+3,890
+8% +$904K
VEU icon
27
Vanguard FTSE All-World ex-US ETF
VEU
$66.3B
$12.5M 1.18%
261,369
-1,360
-0.5% -$63.4K
AAPL icon
28
Apple
AAPL
$4.48T
$12M 1.13%
333,932
-32,948
-9% -$1.08M
XLF icon
29
State Street Financial Select Sector SPDR ETF
XLF
$56.6B
$11.6M 1.09%
486,800
+88,500
+22% +$2.12M
AMZN icon
30
Amazon
AMZN
$2.89T
$11.2M 1.05%
252,780
-10,340
-4% -$431K
FDX icon
31
FedEx
FDX
$73.1B
$10.8M 1.02%
55,245
-100
-0.2% -$19.1K
INTC icon
32
Intel
INTC
$470B
$10.7M 1.01%
296,501
-571
-0.2% -$20.7K
PFE icon
33
Pfizer
PFE
$142B
$9.69M 0.91%
298,433
-10,278
-3% -$324K
KO icon
34
Coca-Cola
KO
$376B
$9.66M 0.91%
227,592
+4,830
+2% +$201K
CHD icon
35
Church & Dwight Co
CHD
$23.2B
$9.24M 0.87%
185,297
-5,000
-3% -$239K
GD icon
36
General Dynamics
GD
$103B
$8.71M 0.82%
46,520
+11,670
+33% +$2.16M
ORCL icon
37
Oracle
ORCL
$371B
$8.38M 0.79%
187,827
+1,320
+0.7% +$55K
SBUX icon
38
Starbucks
SBUX
$123B
$8.36M 0.79%
143,135
-4,521
-3% -$256K
TMO icon
39
Thermo Fisher Scientific
TMO
$211B
$8.25M 0.78%
53,707
-1,755
-3% -$268K
JPM icon
40
JPMorgan Chase
JPM
$933B
$8.15M 0.77%
92,732
-4,855
-5% -$428K
GOOGL icon
41
Alphabet (Google) Class A
GOOGL
$4.19T
$7.79M 0.73%
183,720
-1,380
-0.7% -$58K
MDY icon
42
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$7.67M 0.72%
24,566
-174
-0.7% -$54K
AXP icon
43
American Express
AXP
$228B
$7.67M 0.72%
96,893
+1,590
+2% +$124K
MA icon
44
Mastercard
MA
$505B
$7.39M 0.7%
65,735
CTSH icon
45
Cognizant
CTSH
$24.3B
$7.29M 0.69%
122,452
-4,125
-3% -$237K
IBM icon
46
IBM
IBM
$208B
$7.24M 0.68%
43,465
+1,012
+2% +$170K
ABBV icon
47
AbbVie
ABBV
$442B
$7.22M 0.68%
110,765
+2,845
+3% +$179K
ESRX
48
DELISTED
Express Scripts Holding Company
ESRX
$7.05M 0.66%
106,979
-154,297
-59% -$10.6M
MON
49
DELISTED
Monsanto Co
MON
$6.83M 0.64%
+60,321
New +$6.68M
APH icon
50
Amphenol
APH
$200B
$6.63M 0.62%
372,552
-11,860
-3% -$205K

Similar funds

Chesley Taft & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Chesley Taft & Associates held 281 positions worth $1.06B, up 5% from $1.01B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Chesley Taft & Associates's Q1 2017 filing shows 13 new, 86 increased, 117 reduced and 8 closed positions. Its largest new stake was Monsanto Co: 60,321 shares worth $6.83M. The largest sale was Express Scripts Holding Company, an estimated $10.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Chesley Taft & Associates's largest Q1 2017 buy was Monsanto Co: 60,321 shares worth $6.83M.
  • Chesley Taft & Associates added most to Marathon Petroleum in Q1 2017, an estimated $4.96M increase.
  • Chesley Taft & Associates's biggest Q1 2017 reduction was Express Scripts Holding Company, cutting an estimated $10.6M.
  • Chesley Taft & Associates fully exited Acuity Brands in Q1 2017, selling an estimated $1.74M.
  • Chesley Taft & Associates's ten largest holdings make up 23% of its $1.06B portfolio in Q1 2017.
  • Chesley Taft & Associates opened 13 new positions and closed 8 in Q1 2017.
  • Chesley Taft & Associates's portfolio value rose 5% quarter-over-quarter to $1.06B.

Based on Chesley Taft & Associates's 13F filing for Q1 2017, filed 10 Apr 2017.